BioPharma Dive Dec 18, 2025 Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial
Endpoints News Dec 18, 2025 After year of triumph, Insmed stumbles with chronic rhinosinusitis fail, brings in new asset
Illumina Dec 18, 2025 The Illumina-Myome Partnership That Could Save $200 Billion in U.S. Healthcare - Inside Precision Medicine
BioPharma Dive Dec 18, 2025 Insmed’s ‘win streak’ ends as top drug fails study in chronic nasal condition
FierceBiotech Dec 18, 2025 Takeda looks to 2026 FDA filing for its Sotyktu rival zasocitinib after phase 3 success
FierceBiotech Dec 18, 2025 After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3